Does the NPPB rs198389 G allele raise BNP and predispose to lower circulating volume under stress?

B-type natriuretic peptide (BNP) is a hormone primarily secreted by the heart in response to pressure or volume overload. It serves as a natural counter-regulatory mechanism by promoting the excretion of sodium and water to maintain cardiovascular homeostasis. Genetic variations in the promoter of the gene encoding BNP can influence baseline levels of this hormone, which may impact how the body responds to environmental and physiological stressors.

Evidence for genetic influence on BNP levels

Large-scale cohort studies have firmly established that the NPPB rs198389 A>G variant is a primary genetic determinant of circulating BNP levels.

• Dose-dependent association: In the Atherosclerosis Risk in Communities (ARIC) study (n > 11,000), individuals with the GG genotype exhibited mean plasma NT-proBNP levels approximately 41% higher than those with the AA genotype. The AG genotype showed intermediate levels, demonstrating a clear gene-dosage effect.
• Clinical verification: Data from the STOP-HF trial reinforced these findings, showing significantly higher BNP concentrations in GG carriers (50.7 pg/mL) compared to AA carriers (36.3 pg/mL).
• Functional mechanism: The rs198389 variant is located in the NPPB promoter region. The G allele acts as a functional polymorphism that enhances gene transcription, leading to lifelong higher baseline circulating BNP levels.

Mechanistic pathways of BNP signaling

BNP exerts its effects through the Natriuretic Peptide Receptor-A (NPR-A), triggering an increase in intracellular cyclic guanosine monophosphate (cGMP).

• Renal effects: BNP promotes natriuresis (sodium excretion) and diuresis (water excretion) by dilating the afferent arterioles to increase the glomerular filtration rate (GFR). It also inhibits sodium reabsorption in the collecting ducts and proximal tubules.
• Volume regulation: By facilitating fluid loss, BNP signaling naturally reduces the effective circulating volume. While this protects against hypertension, it may sensitize the body to volume depletion under stress.
• Stress response: Under physiological stressors that require volume conservation—such as postural shifts or extreme environments—elevated BNP signaling can blunt the body's compensatory mechanisms (like sympathetic activation and volume retention), potentially predisposing individuals to lower circulating volume or hypovolemia.

Bottom line

The NPPB rs198389 G allele is strongly associated with higher circulating BNP levels through enhanced gene transcription. Because BNP promotes sodium and water excretion, this genetic profile may predispose individuals to reduced effective circulating volume, particularly when facing stressors that challenge fluid balance.